Novus Therapeutics Announces $10.7 Million Registered Direct Offering Priced At-the-Market - Yahoo Finance

Novus Therapeutics Announces $10.7 Million Registered Direct Offering Priced At-the-Market  Yahoo Finance

Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat ...



Comments

Popular posts from this blog

(2019-2028) Global Otitis Media Market Insights, Epidemiology - TOP Tribune